CERUS CORP — Form 8-K
Filed November 2, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Cerus reported Q3 2026 product revenue of $57.7M (+10% YoY) and total revenue of $64.0M (+6% YoY). Key driver: IFC volume growth ~80% YoY with Q3 U.S. IFC sales of $5.6M (up from $3.9M). Company announced positive topline Phase 3 RedeS results for INTERCEPT RBC system. Cash position: $57.1M at Sept 30 (down from $82.9M at year-end 2025); debt: $63.5M total ($28.5M revolving, $35.0M term loan). Nine-month net loss improved to $5.1M vs. $13.4M prior year. Full-year 2026 product revenue guidance maintained at $229–$231M (+11–12% growth).
Why this rating
Positive trial data and strong IFC growth (+80%) are encouraging; however, revenue represents ~25% of market cap, and RedeS still requires regulatory approval. Moderate operational improvement, not transformational.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.